Eligibility Criteria


Any patients with a diagnosis of cancer who is exposed (or previously has been exposed) to cardiac toxic therapies.

Cardiac toxic therapies includes radiotherapy, anthracyclines, VEGF inhibitors, proteasomal inhibitors, tyrosine kinase inhibitors, immunotherapy, cyclophosphamide.


Consenting to being included on the registry and substudies OR have a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf.